IP Library › Assignment 059211/0304
Patent Assignment
Reel/Frame 059211/0304

Merger and Change of Name

Recorded: 2022-03-09 Pages: 10
Assignors
BIOTIME, INC.
Executed: 2019-08-09
LINEAGE CELL THERAPEUTICS, INC.
Executed: 2019-08-09
Assignee
LINEAGE CELL THERAPEUTICS, INC.
2173 SALK AVENUE, SUITE 200, CARLSBAD, CALIFORNIA, 92008
Covered Property (1)
Compositions and Methods for Induced Tissue Regeneration in Mammalian Species
Application: 17/543,018 →
Publication: US 2022/0090078
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 9, 2022
From: LINEAGE CELL THERAPEUTICS, INC.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 059211/0285 →
Assignment of Assignor's Interest Mar 9, 2022
From: WEST, MICHAEL D.; CHAPMAN, KAREN; STERNBERG, HAL
To: BIOTIME, INC.
Reel/Frame 059211/0320 →
Assignment of Assignor's Interest Mar 11, 2022
From: AGEX THERAPEUTICS, INC.
To: REVERSE BIOENGINEERING, INC.
Reel/Frame 059242/0007 →
Security Interest Nov 10, 2023
From: AGEX THERAPEUTICS, INC.; RECYTE THERAPEUTICS, INC.; REVERSE BIOENGINEERING, INC.
To: JUVENESCENCE LIMITED
Reel/Frame 065529/0594 →